会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Self-triggering CMOS image sensor
    • 自触发CMOS图像传感器
    • US07812879B2
    • 2010-10-12
    • US11928285
    • 2007-10-30
    • Xinqiao LiuHung Do
    • Xinqiao LiuHung Do
    • H04N3/14H04N5/335
    • H04N5/32H04N5/343
    • An image sensor and method for using the image sensor to capture an image are disclosed. The image sensor includes an imaging array, a first block amplifier and a controller. A first plurality of pixels in the imaging array includes pixels having a photodiode connected to a first node by a gate transistor, a reset transistor connected between the first node and a reset node, a pixel amplifier having an input connected to the first node and an output, and an output gate for connecting the pixel amplifier output to an output bus. The sensor has a monitoring mode and an image capture mode. In the monitoring mode the reset node is connected to the first block amplifier whose output is monitored and used to trigger the image capture mode when the output exceeds a predetermined threshold.
    • 公开了一种使用图像传感器拍摄图像的图像传感器和方法。 图像传感器包括成像阵列,第一块放大器和控制器。 成像阵列中的第一多个像素包括具有通过栅晶体管连接到第一节点的光电二极管的像素,连接在第一节点和复位节点之间的复位晶体管,具有连接到第一节点的输入的像素放大器和 输出,以及用于将像素放大器输出连接到输出总线的输出门。 传感器具有监控模式和图像捕捉模式。 在监视模式下,复位节点连接到第一块放大器,其输出被监视并用于当输出超过预定阈值时触发图像捕获模式。
    • 2. 发明申请
    • VARIANT, RECOMBINANT BETA-GLUCOCEREBROSIDASE PROTEINS WITH INCREASED STABILITY AND INCREASED RETAINED CATALYTIC ACTIVITY
    • 变体,具有增加的稳定性和增加的保留催化活性的重组型β-GLUCOCEREBROSIDASE蛋白
    • US20130344054A1
    • 2013-12-26
    • US13884126
    • 2011-11-08
    • Hung Do
    • Hung Do
    • C12N9/24
    • A61K38/47A61K31/445C12N9/2402C12Y302/01045
    • Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases.
    • 本文描述的是重组β-葡糖脑苷脂酶蛋白,其特征在于相对于重组野生型β-葡糖脑苷脂酶具有增加的稳定性。 本文还提供了相对于重组野生型β-葡糖脑苷脂酶具有更多催化活性的变体,重组β-葡糖脑苷脂酶蛋白质。 本文进一步描述的是可以在以下一个或多个位置具有氨基酸变异的变体,重组β-葡糖脑苷脂酶蛋白:316,317,321和145.还描述了制备变体,重组β-葡糖脑苷脂酶蛋白的方法 作为治疗患有溶酶体贮积病的患者的方法。
    • 3. 发明申请
    • Self-Triggering CMOS Image Sensor
    • 自动触发CMOS图像传感器
    • US20090109313A1
    • 2009-04-30
    • US11928285
    • 2007-10-30
    • Xinqiao LiuHung Do
    • Xinqiao LiuHung Do
    • H04N5/335
    • H04N5/32H04N5/343
    • An image sensor and method for using the image sensor to capture an image are disclosed. The image sensor includes an imaging array, a first block amplifier and a controller. A first plurality of pixels in the imaging array includes pixels having a photodiode connected to a first node by a gate transistor, a reset transistor connected between the first node and a reset node, a pixel amplifier having an input connected to the first node and an output, and an output gate for connecting the pixel amplifier output to an output bus. The sensor has a monitoring mode and an image capture mode. In the monitoring mode the reset node is connected to the first block amplifier whose output is monitored and used to trigger the image capture mode when the output exceeds a predetermined threshold.
    • 公开了一种使用图像传感器拍摄图像的图像传感器和方法。 图像传感器包括成像阵列,第一块放大器和控制器。 成像阵列中的第一多个像素包括具有通过栅晶体管连接到第一节点的光电二极管的像素,连接在第一节点和复位节点之间的复位晶体管,具有连接到第一节点的输入的像素放大器和 输出,以及用于将像素放大器输出连接到输出总线的输出门。 传感器具有监控模式和图像捕获模式。 在监视模式下,复位节点连接到第一块放大器,其输出被监视并用于当输出超过预定阈值时触发图像捕获模式。
    • 5. 发明授权
    • Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
    • 将靶向肽结合到重组溶酶体酶上以改进溶酶体贮积病治疗的方法
    • US09545450B2
    • 2017-01-17
    • US14122858
    • 2012-05-25
    • Hung Do
    • Hung Do
    • C12N9/96A61K38/47A61K47/48C07K14/65C12N9/16C12N9/24
    • A61K47/6847A61K38/47A61K47/642C07K14/65C07K2319/00C07K2319/21C07K2319/50C12N9/16C12N9/2402C12N9/96
    • Described herein are methods of making targeting peptides conjugated to recombinant lysosomal enzymes by modifying the amino (N)-terminus and one or more lysine residues on recombinant human lysosomal enzymes using a first crosslinking agent to give rise to first crosslinking agent modified recombinant human lysosomal enzymes, modifying the first amino acid within a short linker at the amino (N)-terminus on a variant IGF-2 peptide using a second crosslinking agent to give rise to a second crosslinking agent modified variant IGF-2 peptide, and then conjugating the first crosslinking agent modified recombinant human lysosomal enzyme to the second crosslinking agent modified variant IGF-2 peptide containing a short linker. Also described herein are conjugates synthesized characterized as having higher affinities for the IGF2/CI-MPR receptor and cellular uptake using the methods disclosed herein. Also described herein are treatment methods using the disclosed conjugates.
    • 本文描述的是通过使用第一交联剂修饰重组人溶酶体酶上的氨基(N)末端和一个或多个赖氨酸残基以产生第一交联剂修饰的重组人溶酶体酶来制备与重组溶酶体酶缀合的靶向肽的方法 使用第二交联剂在变体IGF-2肽上在氨基(N)末端修饰短接头内的第一个氨基酸,以产生第二交联剂修饰的变体IGF-2肽,然后将第一个 交联剂修饰的重组人溶酶体酶至含有短接头的第二交联剂修饰变体IGF-2肽。 本文还描述了使用本文公开的方法合成的缀合物,其特征在于对IGF2 / CI-MPR受体具有较高的亲和力和细胞摄取。 本文还描述了使用所公开的缀合物的治疗方法。
    • 6. 发明申请
    • NOVEL SIGNAL SEQUENCES TO IMPROVE PROTEIN EXPRESSIONS AND SECRETION OF RECOMBINANT ENZYMES AND OTHER PROTEINS
    • 提高蛋白质表达和重组酶及其他蛋白质分泌的新信号序列
    • US20140045216A1
    • 2014-02-13
    • US13988946
    • 2011-11-22
    • Hung Do
    • Hung Do
    • C07K14/47C12N9/24
    • C07K14/47C07K2319/036C12N9/0002C12N9/2402C12N9/2434C12N15/85
    • Polypeptide signal sequences of modified fragments of human immunoglobulin heavy chain binding protein (Bip) are disclosed. Also disclosed are fusion proteins comprising a modified fragment of human immunoglobulin heavy chain binding protein (Bip) operably linked to a heterologous polypeptide. Also disclosed are protein expression vectors comprising a promoter operably linked to a first DNA sequence encoding a signal sequence comprising a modified fragment of human immunoglobulin heavy chain binding protein (Bip) and a second DNA sequence encoding a heterologous polypeptide fused in frame to the first DNA sequence. Further disclosed are methods of producing a polypeptide comprising expressing a fusion protein comprising a polypeptide signal sequences of modified fragments of human immunoglobulin heavy chain binding protein (Bip) operably linked to a heterologous polypeptide and recovering the heterologous polypeptide.
    • 公开了人免疫球蛋白重链结合蛋白(Bip)的修饰片段的多肽信号序列。 还公开了包含可操作地连接到异源多肽的人免疫球蛋白重链结合蛋白(Bip)的修饰片段的融合蛋白。 还公开了包含可操作地连接到编码包含人免疫球蛋白重链结合蛋白(Bip)的修饰片段的信号序列的第一DNA序列的启动子的蛋白质表达载体和编码与第一DNA融合的异源多肽的第二DNA序列 序列。 还公开了生产多肽的方法,其包括表达融合蛋白,其包含可操作地连接到异源多肽的人免疫球蛋白重链结合蛋白(Bip)的修饰片段的多肽信号序列,并回收异源多肽。
    • 8. 发明授权
    • Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
    • 用于改善重组酶和其他蛋白质的蛋白质表达和分泌的信号序列
    • US09279007B2
    • 2016-03-08
    • US13988946
    • 2011-11-22
    • Hung Do
    • Hung Do
    • C07K14/47C12N9/00C12N9/24C12N9/42C12N15/85
    • C07K14/47C07K2319/036C12N9/0002C12N9/2402C12N9/2434C12N15/85
    • Polypeptide signal sequences of modified fragments of human immunoglobulin heavy chain binding protein (Bip) are disclosed. Also disclosed are fusion proteins comprising a modified fragment of human immunoglobulin heavy chain binding protein (Bip) operably linked to a heterologous polypeptide. Also disclosed are protein expression vectors comprising a promoter operably linked to a first DNA sequence encoding a signal sequence comprising a modified fragment of human immunoglobulin heavy chain binding protein (Bip) and a second DNA sequence encoding a heterologous polypeptide fused in frame to the first DNA sequence. Further disclosed are methods of producing a polypeptide comprising expressing a fusion protein comprising a polypeptide signal sequences of modified fragments of human immunoglobulin heavy chain binding protein (Bip) operably linked to a heterologous polypeptide and recovering the heterologous polypeptide.
    • 公开了人免疫球蛋白重链结合蛋白(Bip)的修饰片段的多肽信号序列。 还公开了包含可操作地连接到异源多肽的人免疫球蛋白重链结合蛋白(Bip)的修饰片段的融合蛋白。 还公开了包含可操作地连接于编码包含人免疫球蛋白重链结合蛋白(Bip)的修饰片段的信号序列的第一DNA序列的启动子的蛋白质表达载体和编码与第一DNA融合的异源多肽的第二DNA序列 序列。 还公开了生产多肽的方法,其包括表达融合蛋白,其包含可操作地连接到异源多肽的人免疫球蛋白重链结合蛋白(Bip)的修饰片段的多肽信号序列,并回收异源多肽。
    • 9. 发明申请
    • METHODS FOR COUPLING TARGETING PEPTIDES ONTO RECOMBINANT LYSOSOMAL ENZYMES FOR IMPROVED TREATMENTS OF LYSOSOMAL STORAGE DISEASES
    • 将靶向肽连接到用于改善体液储存疾病治疗的重组体溶菌酶的方法
    • US20140302001A1
    • 2014-10-09
    • US14122858
    • 2012-05-25
    • Hung Do
    • Hung Do
    • C12N9/96A61K38/47A61K47/48
    • A61K47/6847A61K38/47A61K47/642C07K14/65C07K2319/00C07K2319/21C07K2319/50C12N9/16C12N9/2402C12N9/96
    • Described herein are methods of making targeting peptides conjugated to recombinant lysosomal enzymes by modifying the amino (N)-terminus and one or more lysine residues on recombinant human lysosomal enzymes using a first crosslinking agent to give rise to first crosslinking agent modified recombinant human lysosomal enzymes, modifying the first amino acid within a short linker at the amino (N)-terminus on a variant IGF-2 peptide using a second crosslinking agent to give rise to a second crosslinking agent modified variant IGF-2 peptide, and then conjugating the first crosslinking agent modified recombinant human lysosomal enzyme to the second crosslinking agent modified variant IGF-2 peptide containing a short linker. Also described herein are conjugates synthesized characterized as having higher affinities for the IGF2/CI-MPR receptor and cellular uptake using the methods disclosed herein. Also described herein are treatment methods using the disclosed conjugates.
    • 本文描述的是通过使用第一交联剂修饰重组人溶酶体酶上的氨基(N)末端和一个或多个赖氨酸残基以产生第一交联剂修饰的重组人溶酶体酶来制备与重组溶酶体酶缀合的靶向肽的方法 使用第二交联剂在变体IGF-2肽上在氨基(N)末端修饰短接头内的第一个氨基酸,以产生第二交联剂修饰的变体IGF-2肽,然后将第一个 交联剂修饰的重组人溶酶体酶至含有短接头的第二交联剂修饰变体IGF-2肽。 本文还描述了使用本文公开的方法合成的缀合物,其特征在于对IGF2 / CI-MPR受体具有较高的亲和力和细胞摄取。 本文还描述了使用所公开的缀合物的治疗方法。